MedTrace Logo

CTP Imaging of Lung Cancer

NCT01823094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2016-01-26

No results posted yet for this study

Summary

Investigators hope to learn more about how to use computed tomography (CT) scans to measure blood flow in lung tumors and how it may change in response to treatment. This measurement technique is called computed tomography perfusion (CTP). CT scanners use X-rays to produce 3-dimensional images of the body.

Currently, doctors determine the response to treatment by measuring the size of the tumor. Investigators are trying to find out if measuring the blood flow in the tumor is equal to or better than measuring the size of the tumor.

Conditions

  • Non Small Cell Lung Cancer

Sponsors & Collaborators

  • Radiological Society of North America

    collaborator OTHER

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Friedrich Knollmann, MD, PhD · Univeristy of California, Davis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01823094 on ClinicalTrials.gov